Valo Health

About:

Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.

Website: https://www.valohealth.com/

Twitter/X: valohealth

Top Investors: Invus, PSP Investments, Flagship Pioneering, Koch Disruptive Technologies, Atinum Partners

Description:

Valo Health, Inc (Valo) is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics. Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal Computational Platform™ is an end-to-end drug discovery and development platform with a unified architecture designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs, initially focused on cardiovascular metabolic renal, oncology, and neurodegenerative disease. Founded by Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, and New York, NY. To learn more, visit valohealth.com.

Total Funding Amount:

$460M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

ir(AT)valohealth.com

Founders:

David Berry, Noubar Afeyan

Number of Employees:

101-250

Last Funding Date:

2022-10-28

IPO Status:

Private

© 2025 bioDAO.ai